QMatter develops a quantum compression technology that reduces the size of complex quantum problems to their essential core so they can be computed on existing quantum and classical systems. The approach aims to extend capabilities of current and next-generation hardware by improving performance of classical algorithms and broadening the set of tractable problems. QMatter is initially focused on life sciences, working with pharmaceutical and biotechnology companies to improve simulations and accelerate R&D. The company is also building physics-informed data libraries intended to support training of advanced machine-learning models. Financially, QMatter has just completed a $1.2 million pre-seed round led by 55 North with participation from XTX Ventures, Bellstate Oy, and the Conception X Angel Syndicate. With the new funding, it plans to expand its platform and scale its simulation capabilities for scientific and industrial applications.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2026